Maximus, Inc. $MMS Stock Holdings Lifted by Bank of New York Mellon Corp

Bank of New York Mellon Corp increased its holdings in Maximus, Inc. (NYSE:MMS) by 1.6% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 549,369 shares of the health services provider’s stock after buying an additional 8,434 shares during the period. Bank of New York Mellon Corp’s holdings in Maximus were worth $38,566,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of MMS. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in shares of Maximus during the first quarter valued at approximately $2,115,000. AlphaQuest LLC boosted its position in Maximus by 142.0% during the 2nd quarter. AlphaQuest LLC now owns 8,663 shares of the health services provider’s stock valued at $608,000 after purchasing an additional 5,083 shares during the period. Nordea Investment Management AB grew its stake in Maximus by 0.6% during the 2nd quarter. Nordea Investment Management AB now owns 64,829 shares of the health services provider’s stock worth $4,542,000 after buying an additional 382 shares during the last quarter. Keeler Thomas Management LLC acquired a new stake in Maximus in the second quarter worth $1,179,000. Finally, Exchange Traded Concepts LLC lifted its stake in Maximus by 2.0% in the second quarter. Exchange Traded Concepts LLC now owns 11,870 shares of the health services provider’s stock valued at $833,000 after buying an additional 228 shares during the last quarter. Institutional investors own 97.21% of the company’s stock.

Insider Buying and Selling at Maximus

In related news, insider Michelle F. Link sold 1,610 shares of Maximus stock in a transaction dated Wednesday, October 1st. The stock was sold at an average price of $90.86, for a total value of $146,284.60. Following the transaction, the insider owned 13,508 shares of the company’s stock, valued at approximately $1,227,336.88. This trade represents a 10.65% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.60% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several equities analysts have recently commented on the stock. Zacks Research lowered shares of Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 27th. Weiss Ratings raised shares of Maximus from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, October 8th. Two investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $90.00.

Maximus Trading Down 2.4%

Maximus stock opened at $80.54 on Thursday. The firm has a market cap of $4.54 billion, a price-to-earnings ratio of 14.83 and a beta of 0.57. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $92.50. The firm’s 50 day moving average price is $87.00 and its two-hundred day moving average price is $78.91. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.27 and a current ratio of 2.27.

Maximus Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, December 1st. Stockholders of record on Friday, November 14th will be issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.5%. The ex-dividend date of this dividend is Friday, November 14th. Maximus’s dividend payout ratio is currently 22.10%.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.